Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival

D.j. Noble; E. Doyle; G. Tramonti; A.b. Law; A. Sundaramurthy; J.p. Brush; J. Keanie; C. Wood; P. Drewell; W. Keough; D.b. Mclaren

doi:10.1016/j.clon.2021.11.009

Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival

D.j. Noble, E. Doyle, G. Tramonti, A.b. Law, A. Sundaramurthy, J.p. Brush, J. Keanie, C. Wood, P. Drewell, W. Keough, D.b. Mclaren^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Clinical Oncology
DOIs	https://doi.org/10.1016/j.clon.2021.11.009
Publication status	Published - 28 Nov 2021

Access to Document

10.1016/j.clon.2021.11.009

Binder1
This is a pre-copyedited, author-produced version of an article accepted for publication in Clincial Oncology following peer review. The version of record "Noble DJ et al., Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival, Clinical Oncology, https://doi.org/10.1016/ j.clon.2021.11.009"
Accepted author manuscript, 947 KB

https://linkinghub.elsevier.com/retrieve/pii/S0936655521004283

Cite this

Noble, D. J., Doyle, E., Tramonti, G., Law, A. B., Sundaramurthy, A., Brush, J. P., Keanie, J., Wood, C., Drewell, P., Keough, W., & Mclaren, D. B. (2021). Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival. Clinical Oncology. https://doi.org/10.1016/j.clon.2021.11.009

@article{189786cebc1445029252c1dc743cdb08,

title = "Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival",

author = "D.j. Noble and E. Doyle and G. Tramonti and A.b. Law and A. Sundaramurthy and J.p. Brush and J. Keanie and C. Wood and P. Drewell and W. Keough and D.b. Mclaren",

year = "2021",

month = nov,

day = "28",

doi = "10.1016/j.clon.2021.11.009",

language = "English",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier",

}

Noble, DJ, Doyle, E, Tramonti, G, Law, AB, Sundaramurthy, A, Brush, JP, Keanie, J, Wood, C, Drewell, P, Keough, W & Mclaren, DB 2021, 'Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival', Clinical Oncology. https://doi.org/10.1016/j.clon.2021.11.009

TY - JOUR

T1 - Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival

AU - Noble, D.j.

AU - Doyle, E.

AU - Tramonti, G.

AU - Law, A.b.

AU - Sundaramurthy, A.

AU - Brush, J.p.

AU - Keanie, J.

AU - Wood, C.

AU - Drewell, P.

AU - Keough, W.

AU - Mclaren, D.b.

PY - 2021/11/28

Y1 - 2021/11/28

U2 - 10.1016/j.clon.2021.11.009

DO - 10.1016/j.clon.2021.11.009

M3 - Article

SN - 0936-6555

JO - Clinical Oncology

JF - Clinical Oncology

ER -